Answers are grounded in this paper and cite their sources.
TabSyM enhances predictive accuracy in gastric cancer patients using omics data, suggesting strong utility for cross-cohort analysis.
Machine learning applications in biomedicine such as omics data analysis are frequently hindered by datasets that are small, high-dimensional, and affected by batch effects across different patient cohorts. To address these challenges, we introduce TabSyM, a modular generative pipeline that synthesizes high-quality, task-relevant data to improve predictive modeling. TabSyM integrates three key stages: it extends a diffusion-based model (TabDDPM) to generate new omics data, employs a novel task-aware sampling mechanism guided by Bayesian optimization to select the most informative synthetic samples, and uses a Multi-Domain Adversarial Network (MDAN) to align data distributions for cross-cohort generalization. We validated our pipeline on a challenging, real-world task of predicting 3-year survival in gastric cancer patients from high-dimensional scRNA-seq data across five cohorts. The full TabSyM pipeline achieved a 30.2% AUROC improvement over the best tree-based models and an 11.5% AUROC gain over leading automated machine learning frameworks. Furthermore, the generative and sampling components are model-agnostic and can substantially boost the performance of classical models like XGBoost independently. These results establish that combining generative modeling with task-aware sampling and domain adaptation provides a robust and effective strategy for overcoming critical data limitations in biomedical tabular data analysis.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: